Prairiewood Capital’s Ironwood Pharmaceuticals IRWD Stock Holding History

Prairiewood Capital’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-24,691	Closed	-$17.7K	–	82
2025 Q2	$17.7K	Sell	24,691 -9,033	-27%	-$7.09K	0.01%	77
2025 Q1	$49.6K	Sell	33,724 -951	-3%	-$2.27K	0.02%	73
2024 Q4	$154K	Sell	34,675 -4,631	-12%	-$18.8K	0.07%	73
2024 Q3	$162K	Hold	39,306	–	–	0.07%	77
2024 Q2	$256K	Hold	39,306	–	–	0.12%	68
2024 Q1	$342K	Sell	39,306 -1,775	-4%	-$21.5K	0.16%	61
2023 Q4	$470K	Hold	41,081	–	–	0.24%	57
2023 Q3	$396K	Hold	41,081	–	–	0.26%	61
2023 Q2	$437K	Buy	41,081 +12,848	+46%	+$138K	0.29%	58
2023 Q1	$297K	Buy	+28,233	New	+$316K	0.2%	65

Other funds holding IRWD

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Prairiewood Capital's IRWD Position: Q3 2025 in Review

Prairiewood Capital sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2025, closing a stake of 24,691 shares — an estimated $17.7K sold.

Prairiewood Capital first reported a position in IRWD in Q1 2023 and held it in 10 quarters. The position peaked at $470K in Q4 2023. 166 funds tracked by Wall St. Rank hold IRWD as of Q3 2025.

Prairiewood Capital reported no remaining Ironwood Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
Prairiewood Capital sold 24,691 Ironwood Pharmaceuticals shares in Q3 2025, an estimated $17.7K.
Prairiewood Capital first reported a position in Ironwood Pharmaceuticals in Q1 2023 and held it in 10 quarters.
Prairiewood Capital's Ironwood Pharmaceuticals position peaked at $470K in Q4 2023.
166 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2025.

Based on Prairiewood Capital's 13F filing for Q3 2025, filed 14 Oct 2025.